39 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
(Francis Knuettel II) (filed herewith).
10.4+
Form of Restricted Stock Unit Agreement under the Chromocell Therapeutics Corporation 2023 Equity Incentive … ).
10.5+
Form of Stock Option Agreement under the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.6 to Registrant’s
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
(Francis Knuettel II) (filed herewith).
10.4+
Form of Restricted Stock Unit Agreement under the Chromocell Therapeutics Corporation 2023 Equity Incentive … ).
10.5+
Form of Stock Option Agreement under the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.6 to Registrant’s
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
under the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.5 to Registrant’s Registration Statement on Form S-8, filed … Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.6 to Registrant’s Registration Statement on Form S-8, filed with the SEC on April 15, 2024
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock … , discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct also could
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock … , discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct also could
10-K
EX-97.1
gn0 rllu0zf
16 Apr 24
Annual report
4:48pm
10-K
EX-19.1
a5c5lvc32tg8nvsf9ryq
16 Apr 24
Annual report
4:48pm
10-K
qflkbf
16 Apr 24
Annual report
4:48pm
S-8
EX-4.5
axgr54k za4myexwmgzo
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-4.4
51eoz8k
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-4.6
ovl83s6c luat
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-5.1
itr540hrklyc0
12 Apr 24
Registration of securities for employees
7:22pm
S-8
7ml iscy2a
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-107
2znjp8zec
12 Apr 24
Registration of securities for employees
7:22pm
8-K
z54dwj
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-1.1
zqfz wysy
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
bdia9ce gbl2w9
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
v89wegqdrw1lf75xw3qi
20 Feb 24
Prospectus supplement with pricing info
5:28pm